Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
LPTN vs. ETF Alternatives
Lpath Inc is a biotechnology company engaged in the discovery and development of lipidomic-based therapeutic antibodies to treat a wide range of human diseases. The Company's product candidates include iSONEP, ASONEP, Lpathomab, and ImmuneY2 Technology.
Other News & PR